Call(s) to Action: Please stay tuned for a report on two Pharmaceutical companies competing to use a cannabis-based compound to treat a specific condition in children. One of the companies is a bullish call, and the other bearish. Here are […]
CBAK made false and misleading statements in its July 28, 2014 press release; We hope that the NASDAQ will not take CBAK management’s statements lightly; The company has still not addressed the fact that it just lost its primary revenue-generating […]
CBAK lost a primary operating asset to foreclosure, which should result in the company reporting little to no revenue when it files its Q4 2014 September results. Loss of asset speaks volumes. CBAK hoped to sell assets to fund future […]
Call(s) to Action: ESYS ($12.11, up > 13% in early trading) handily beats analyst EPS estimates by 62% with EPS of $0.26 vs analyst estimates of $0.16. However, the company offers limited commentary and can experience EPS volatility quarter to […]
Call(s) to Action: Shorting CBAK. Main subsidiary defaults on loan payment. Complicated terms of this transaction result in the company only owning two remaining subsidiaries that we believe are currently non-operating. Here are the stories that the GeoTeam is following […]
Call(s) to Action: On June 26, 2014, Penny Stock Realist (“PSR”) published a short thesis report on WSTI. This author believes shares of WSTI are worth “somewhere near $0”. PSR talking points included: A very overly bullish $1 million financed […]
Call(s) to Action – Possible Short Opportunity: CREG ($1.88) – Appears that an institutional owner of CREG shares, Carlyle Asia Growth Partners, intends to sell its shares in the open market. Carlyle Asia Growth Partners owns around 12 million shares. […]
Calls to Action: None Here are the stories that the GeoTeam is following today… (Please see full disclosures at bottom) General Highlights: ChinaHybrid JRJC ($4.68) – Reports record Q1 2014 revenues, narrows loss from prior year. CMGE (Halted) – Yesterday, […]